🇺🇸 Klaricid based triple therapy in United States

Klaricid based triple therapy (Klaricid based triple therapy) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Klaricid based triple therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Klaricid based triple therapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Klaricid based triple therapy in United States?

National Taiwan University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.